AU3650197A - Mutated antibody-dependent infection enhancing domains of hiv - Google Patents

Mutated antibody-dependent infection enhancing domains of hiv

Info

Publication number
AU3650197A
AU3650197A AU36501/97A AU3650197A AU3650197A AU 3650197 A AU3650197 A AU 3650197A AU 36501/97 A AU36501/97 A AU 36501/97A AU 3650197 A AU3650197 A AU 3650197A AU 3650197 A AU3650197 A AU 3650197A
Authority
AU
Australia
Prior art keywords
hiv
mutated antibody
dependent infection
infection enhancing
enhancing domains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU36501/97A
Inventor
William M. Mitchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt University filed Critical Vanderbilt University
Publication of AU3650197A publication Critical patent/AU3650197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU36501/97A 1996-07-05 1997-07-02 Mutated antibody-dependent infection enhancing domains of hiv Abandoned AU3650197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2166896P 1996-07-05 1996-07-05
US60021668 1996-07-05
PCT/US1997/011667 WO1998001570A2 (en) 1996-07-05 1997-07-02 Mutated antibody-dependent infection enhancing domains of hiv

Publications (1)

Publication Number Publication Date
AU3650197A true AU3650197A (en) 1998-02-02

Family

ID=21805497

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36501/97A Abandoned AU3650197A (en) 1996-07-05 1997-07-02 Mutated antibody-dependent infection enhancing domains of hiv

Country Status (2)

Country Link
AU (1) AU3650197A (en)
WO (1) WO1998001570A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1165798A2 (en) * 1999-03-29 2002-01-02 Statens Serum Institut Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
EP2748186A1 (en) * 2011-08-23 2014-07-02 Skau Aps Method for removing immunosuppresive properties of hiv envelope glycoproteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019510A (en) * 1987-10-28 1991-05-28 Institut Pasteur Isolation, molecular cloning and sequencing of an HIV-1 isolate from a Gabonese donor
GB2316681B (en) * 1993-09-16 1998-04-15 Dimminaco Ag Sa Ltd Antigenically active proteins/polypeptides and coronavirus vaccines containing the same
JP2000501381A (en) * 1995-10-18 2000-02-08 バンダービルト ユニバーシティー Induction of hormonal immune regulation of mucosal immune response

Also Published As

Publication number Publication date
WO1998001570A2 (en) 1998-01-15
WO1998001570A3 (en) 1998-02-26

Similar Documents

Publication Publication Date Title
AU2901695A (en) Graphite-loaded silicon carbide
AU6187798A (en) Preparation of carbide nanorods
AU3927493A (en) Improved enzyme electrodes
AU9069798A (en) Propylene oxide purification
AU9128798A (en) Genotyping of human cyp3a4
AU3095095A (en) Rna component of telomerase
AU6473594A (en) Disposable undergarment
AU6472594A (en) Disposable undergarment
AU3789399A (en) Indolicidin analogs and methods of using same
AU3552697A (en) Novel treatment of leptine resistance
AU5758594A (en) Treatment of viral infections
AU1697197A (en) Immunoconjugate for the treatment of aids
AU1750497A (en) Compounds capable of inhibiting hiv-1 infection
AU6472694A (en) Disposable undergarment
AU3650197A (en) Mutated antibody-dependent infection enhancing domains of hiv
AU4422897A (en) Cross-dimerization of olefins
AU3530395A (en) Treatment of viral infections
AU1035495A (en) Improved polymerase
AU3770097A (en) Batch preheater
AUPP385598A0 (en) Purification of antibodies
AU4140197A (en) Ceramic hob
AU5218196A (en) Purification of pentafluoroethane
AU7272094A (en) Preparation of electrode
AU8102498A (en) Preparation of diaryl-benzopyrans
AU1979397A (en) Peptidomimetics for the treatment of hiv infection